Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    October 2018
  1. SOUWER ETD, Hultink D, Bastiaannet E, Hamaker ME, et al
    The Prognostic Value of a Geriatric Risk Score for Older Patients with Colorectal Cancer.
    Ann Surg Oncol. 2018 Oct 25. pii: 10.1245/s10434-018-6867.
    PubMed     Text format     Abstract available


  2. CREASY JM, D'Angelica MI
    ASO Author Reflections: Primary Tumor Location and Long-Term Survival After Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2018 Oct 17. pii: 10.1245/s10434-018-6918.
    PubMed     Text format    


  3. YOKOI K, Harada H, Yokota K, Ishii S, et al
    Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6865.
    PubMed     Text format     Abstract available


  4. PINAR I, Fransgaard T, Thygesen LC, Gogenur I, et al
    Long-Term Outcomes of Robot-Assisted Surgery in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6862.
    PubMed     Text format     Abstract available


  5. SHINTO E, Hida JI, Ike H, Kobayashi H, et al
    A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy.
    Ann Surg Oncol. 2018 Oct 1. pii: 10.1245/s10434-018-6786.
    PubMed     Text format     Abstract available


    September 2018
  6. WEERINK LBM, Gant CM, van Leeuwen BL, de Bock GH, et al
    Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6766.
    PubMed     Text format     Abstract available


  7. SPINOGLIO G, Bianchi PP, Marano A, Priora F, et al
    Robotic Versus Laparoscopic Right Colectomy with Complete Mesocolic Excision for the Treatment of Colon Cancer: Perioperative Outcomes and 5-Year Survival in a Consecutive Series of 202 Patients.
    Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6752.
    PubMed     Text format     Abstract available


  8. ANGKA L, Martel AB, Kilgour M, Jeong A, et al
    Natural Killer Cell IFNgamma Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.
    Ann Surg Oncol. 2018 Sep 5. pii: 10.1245/s10434-018-6691.
    PubMed     Text format     Abstract available


    August 2018
  9. MIRKIN KA, Kulaylat AS, Hollenbeak CS, Messaris E, et al
    Prognostic Significance of Tumor Deposits in Stage III Colon Cancer.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6661.
    PubMed     Text format     Abstract available


    July 2018
  10. LEE DW, Han SW, Kang JK, Bae JM, et al
    Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6681.
    PubMed     Text format     Abstract available


  11. MARTIN L, Hopkins J, Malietzis G, Jenkins JT, et al
    Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
    Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6652.
    PubMed     Text format     Abstract available


    May 2018
  12. OKUNO M, Goumard C, Kopetz S, Vega EA, et al
    RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6517.
    PubMed     Text format     Abstract available


  13. NARAYANAN S, Kawaguchi T, Yan L, Peng X, et al
    Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 16. pii: 10.1245/s10434-018-6506.
    PubMed     Text format     Abstract available


  14. VAN DEN BROEK J, Geenen R, Heijnen L, Kobus C, et al
    Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
    Ann Surg Oncol. 2018 May 14. pii: 10.1245/s10434-018-6501.
    PubMed     Text format     Abstract available


  15. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
    Peritoneal Metastases in Colorectal Cancer.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
    PubMed     Text format    


    April 2018
  16. BABCOCK BD, Aljehani MA, Jabo B, Choi AH, et al
    High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Ann Surg Oncol. 2018 Apr 19. pii: 10.1245/s10434-018-6484.
    PubMed     Text format     Abstract available


  17. WEISER MR
    AJCC 8th Edition: Colorectal Cancer.
    Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
    PubMed     Text format    


    March 2018
  18. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
    Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
    Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
    PubMed     Text format     Abstract available


  19. SIMONEAU E, Vauthey JN
    Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
    Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
    PubMed     Text format    


  20. FLAHERTY DC, Jalas JR, Sim MS, Stojadinovic A, et al
    The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
    Ann Surg Oncol. 2018 Mar 12. pii: 10.1245/s10434-018-6405.
    PubMed     Text format     Abstract available


  21. NAGATA H, Ishihara S, Oba K, Tanaka T, et al
    Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.
    Ann Surg Oncol. 2018 Mar 5. pii: 10.1245/s10434-018-6403.
    PubMed     Text format     Abstract available


    February 2018
  22. HOPKINS JJ, Skubleny D, Bigam DL, Baracos VE, et al
    Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
    Ann Surg Oncol. 2018 Feb 27. pii: 10.1245/s10434-018-6395.
    PubMed     Text format     Abstract available


    December 2017
  23. TAKAHASHI G, Yamada T, Iwai T, Takeda K, et al
    Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
    Ann Surg Oncol. 2017 Dec 12. pii: 10.1245/s10434-017-6300.
    PubMed     Text format     Abstract available


    November 2017
  24. CREASY JM, Sadot E, Koerkamp BG, Chou JF, et al
    The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6264.
    PubMed     Text format     Abstract available


  25. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    PubMed     Text format     Abstract available


    October 2017
  26. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    PubMed     Text format    


  27. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    PubMed     Text format     Abstract available


  28. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    PubMed     Text format    


  29. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    PubMed     Text format    


  30. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    PubMed     Text format    


  31. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    PubMed     Text format     Abstract available


  32. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    PubMed     Text format     Abstract available


  33. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    PubMed     Text format     Abstract available


    September 2017
  34. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    PubMed     Text format     Abstract available


  35. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
    External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
    PubMed     Text format     Abstract available


    August 2017
  36. LORIMER PD, Motz BM, Kirks RC, Boselli DM, et al
    Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017;24:2095-2103.
    PubMed     Text format     Abstract available


  37. WHEALON MD, Gahagan JV, Sujatha-Bhaskar S, O'Leary MP, et al
    Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Ann Surg Oncol. 2017;24:2122-2128.
    PubMed     Text format     Abstract available


  38. SCHNEIDER MA, Eshmuminov D, Lehmann K
    Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.
    Ann Surg Oncol. 2017;24:2224-2232.
    PubMed     Text format     Abstract available


  39. SEEBERG LT, Brunborg C, Waage A, Hugenschmidt H, et al
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:2113-2121.
    PubMed     Text format     Abstract available


    June 2017
  40. YAMASHITA S, Sakamoto Y, Yamamoto S, Takemura N, et al
    Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Ann Surg Oncol. 2017;24:1557-1568.
    PubMed     Text format     Abstract available


  41. LIM TZ, Chan DKH, Tan KK
    Endoscopic Stenting Does Not Worsen Long Term Outcomes Amongst Patients Presenting with Obstruction from Colorectal Cancers.
    Ann Surg Oncol. 2017;24:1618-1625.
    PubMed     Text format     Abstract available


    May 2017
  42. HAWKINS AT, Wells KO, Krishnamurty DM, Hunt SR, et al
    Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
    Ann Surg Oncol. 2017;24:1195-1201.
    PubMed     Text format     Abstract available


  43. ACHARYA A, Markar SR, Matar M, Ni M, et al
    Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
    Ann Surg Oncol. 2017;24:1165-1173.
    PubMed     Text format     Abstract available


  44. VYCHNEVSKAIA K, Dumont F, Agostini J, Julie C, et al
    Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
    Ann Surg Oncol. 2017;24:1304-1311.
    PubMed     Text format     Abstract available


  45. YAMASHITA S, Loyer E, Kang HC, Aloia TA, et al
    Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.
    Ann Surg Oncol. 2017;24:1376-1377.
    PubMed     Text format     Abstract available


  46. DREYER SB, Powell AG, McSorley ST, Waterston A, et al
    The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.
    Ann Surg Oncol. 2017;24:1295-1303.
    PubMed     Text format     Abstract available


  47. KULAYLAT AS, Hollenbeak CS, Stewart DB Sr
    Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Ann Surg Oncol. 2017;24:1281-1288.
    PubMed     Text format     Abstract available


    April 2017
  48. CHOULIARAS K, Levine EA, Fino N, Shen P, et al
    Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2017;24:890-897.
    PubMed     Text format     Abstract available


  49. DHIR M, Ramalingam L, Shuai Y, Pakrafter S, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
    Ann Surg Oncol. 2017;24:875-883.
    PubMed     Text format     Abstract available


  50. CHAN CH, Liesenfeld LF, Ferreiro-Neira I, Cusack JC Jr, et al
    Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.
    Ann Surg Oncol. 2017;24:931-938.
    PubMed     Text format     Abstract available


  51. MEHTA AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, et al
    Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
    Ann Surg Oncol. 2017;24:990-997.
    PubMed     Text format     Abstract available


  52. IHEMELANDU C
    Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.
    Ann Surg Oncol. 2017;24:884-889.
    PubMed     Text format     Abstract available


  53. IHEMELANDU C, Sugarbaker PH
    Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Ann Surg Oncol. 2017;24:898-905.
    PubMed     Text format     Abstract available


  54. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    PubMed     Text format     Abstract available


  55. VIGANO L, Lopci E, Costa G, Rodari M, et al
    Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Ann Surg Oncol. 2017;24:1029-1036.
    PubMed     Text format     Abstract available


  56. MACHADO MA, Surjan R, Basseres T, Makdissi F, et al
    Total Laparoscopic Reversal ALPPS.
    Ann Surg Oncol. 2017;24:1048-1049.
    PubMed     Text format     Abstract available


    March 2017
  57. WAITE K, Youssef H
    The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Ann Surg Oncol. 2017;24:705-720.
    PubMed     Text format     Abstract available


  58. THORGERSEN EB, Goscinski MA, Spasojevic M, Solbakken AM, et al
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2017;24:721-728.
    PubMed     Text format     Abstract available


    February 2017
  59. LEE DY, Teng A, Pedersen RC, Tavangari FR, et al
    Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Ann Surg Oncol. 2017;24:311-318.
    PubMed     Text format     Abstract available


  60. CHOI SH, Choi GH, Han DH, Kwon SW, et al
    Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification.
    Ann Surg Oncol. 2017;24:554-555.
    PubMed     Text format     Abstract available


    January 2017
  61. SIOULAS VD, Jorge S, Chern JY, Schiavone MB, et al
    Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.
    Ann Surg Oncol. 2017;24:251-256.
    PubMed     Text format     Abstract available


  62. WIMMER K, Schwarz C, Szabo C, Bodingbauer M, et al
    Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:236-243.
    PubMed     Text format     Abstract available


  63. BEPPU N, Kimura F, Aihara T, Doi H, et al
    Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (</=5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Del
    Ann Surg Oncol. 2017;24:219-226.
    PubMed     Text format     Abstract available


  64. MARGONIS GA, Sasaki K, Andreatos N, Kim Y, et al
    KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:264-271.
    PubMed     Text format     Abstract available


  65. DHIR M, Jones HL, Shuai Y, Clifford AK, et al
    Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
    Ann Surg Oncol. 2017;24:150-158.
    PubMed     Text format     Abstract available


  66. ORCUTT ST, Massarweh NN, Li LT, Artinyan A, et al
    Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.
    Ann Surg Oncol. 2017;24:23-30.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: